HK

Hema Kannan

Active Director Director DIN 00041316
DIN 00041316 First appointment Apr 1999 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Apr 1999
Shareholding value •••• Premium profile

About Hema Kannan

Data last updated:

Hema Kannan is a Director at Novacare Drug Specialities Private Limited (since 2006), Director at Novacare Packaging Private Limited (since 1999) and Director at Medworld Pharmaceuticals Private Limited (since 2009). The companies operate in Pharma and Information Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹14.19 Cr; the largest is Novacare Drug Specialities Private Limited at ₹9.04 Cr (FY 2025). Earlier, Hema Kannan was a Director at Novacare Healthcare Solutions Private Limited (2018) and Director at Novacare Medical Supplies Private Limited (from 2011).

DIN 00041316
Primary Designation Director
Industry Pharma
First Appointment 16 Apr 1999
Oldest Company Age 34 yrs
Largest company Novacare Drug Specialities Private Limited · ₹9.04 Cr (FY 2025)
Combined revenue ₹14.19 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Nov 20061992₹9.04 Cr (FY 2025)Active
Novacare Packaging Private Limited U24230MH1999PTC119467
Director16 Apr 19991999₹4.97 Cr (FY 2025)Active
Director20 May 20092006₹18.6 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 May 20182018₹527 Cr (FY 2025)Active
Director14 Dec 20112011₹12,000 (FY 2023)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Hema Kannan

NameDINCompanyDesignation
Ramakrishnan Kannan00017321Novacare Drug Specialities Private Limited , Novacare Packaging Private Limited and 1 moreManaging Director

Directorship timeline

Open interactive timeline →
Novacare Packaging Private Limited
Novacare Drug Specialities Private Limited
Medworld Pharmaceuticals Private Limited
Novacare Medical Supplies Private Limited
Premium access

Shareholding and investment profile for Hema Kannan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hema Kannan

Hema Kannan currently holds 3 directorships: Novacare Drug Specialities Private Limited (Director, since 03 Nov 2006, revenue ₹9.04 Cr (FY 2025)); Novacare Packaging Private Limited (Director, since 16 Apr 1999, revenue ₹4.97 Cr (FY 2025)); Medworld Pharmaceuticals Private Limited (Director, since 20 May 2009, revenue ₹18.6 Lakh (FY 2025)).

Hema Kannan was first appointed on 16 Apr 1999 as Director at Novacare Packaging Private Limited. The most recent appointment on record is 25 May 2018 at Novacare Healthcare Solutions Private Limited.

The 3 current companies of Hema Kannan that report revenue have a combined latest revenue of ₹14.19 Cr: Novacare Drug Specialities Private Limited ₹9.04 Cr (FY 2025); Novacare Packaging Private Limited ₹4.97 Cr (FY 2025); Medworld Pharmaceuticals Private Limited ₹18.6 Lakh (FY 2025).

Hema Kannan held 2 earlier board appointments: Novacare Healthcare Solutions Private Limited (Director, 25 May 2018 to 09 Aug 2018); Novacare Medical Supplies Private Limited (Director, from 14 Dec 2011).

The current boards of Hema Kannan's companies include Ramakrishnan Kannan (Novacare Drug Specialities Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available